Insights into type 2 diabetes mellitus in atrial fibrillation patients: a proteomics approach

被引:0
|
作者
Atzemian, N. [1 ]
Androutsopoulou, V [2 ]
Portokallidou, K. [1 ]
Leonidis, G. [1 ]
Pallikarou, M. [1 ]
Ragia, G. [1 ]
Karangelis, D. [2 ]
Mikroulis, D. [2 ]
Manolopoulos, V. G. [1 ]
机构
[1] Democritus Univ Thrace, Individualised Med & Pharmacol Res Solut Ctr IMPRe, Med Sch, Alexandroupolis, Greece
[2] Gen Univ Hosp Alexandroupolis, Dept Cardiac Surg, Alexandroupolis, Greece
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [11] Type 2 Diabetes Mellitus and Risk of Incident Atrial Fibrillation in Women
    Schoen, Tobias
    Pradhan, Aruna D.
    Albert, Christine M.
    Conen, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (15) : 1421 - 1428
  • [12] CARDIOMETABOLIC RISK FACTORS FOR ATRIAL FIBRILLATION IN TYPE 2 DIABETES MELLITUS
    Gaman, M.
    Dobrica, E. C.
    Pascu, E. G.
    Cozma, M. A.
    Epingeac, M. E.
    Gaman, A. M.
    Diaconu, C. C.
    JOURNAL OF HYPERTENSION, 2019, 37 : E96 - E96
  • [13] Electrical Remodelling Contributes to Atrial Fibrillation in Type 2 Diabetes Mellitus
    Bohne, Loryn J.
    Jansen, Hailey J.
    Moghtadaei, Motahareh
    Rose, Robert A.
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 346A - 346A
  • [14] Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Specific Features of Development and Antirecurrence Therapy
    Kanorsky, S. G.
    Kanorskaya, Yu. S.
    KARDIOLOGIYA, 2010, 50 (07) : 31 - 37
  • [15] Atrial fibrillation is associated with increased mean platelet volume in patients with type 2 diabetes mellitus
    Turgut, Okan
    Zorlu, Ali
    Kilicli, Fatih
    Cinar, Ziynet
    Yucel, Hasan
    Tandogan, Izzet
    Dokmetas, Hatice Sebila
    PLATELETS, 2013, 24 (06) : 493 - 497
  • [16] Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus
    Chowdhury, Krishna Roy
    Michaud, Jonathan
    Yu, Oriana Hoi Yun
    Yin, Hui
    Azoulay, Laurent
    Renoux, Christel
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (10) : 1794 - 1803
  • [17] Antithrombotics prescription pattern and clinical outcomes in atrial fibrillation patients with type 2 diabetes mellitus
    Hoo, Y. Y.
    Mazlan-Kepli, W.
    Habizal, N. H.
    Ismail, M. I.
    Wong, Y. P.
    Rosnan, N. H.
    Mohamed, S.
    Abd Ghani, A. R.
    Yusof, H. Mohd
    Ramaiah, A. R. Abdullah
    Selvaraj, K.
    Abd Malek, A. M.
    Ghapar, A. K. Abdul
    EUROPEAN HEART JOURNAL, 2023, 44 : 152 - 152
  • [18] High bodyweight variability and increased risk of atrial fibrillation in patients with type 2 diabetes mellitus
    Lee, H. J.
    Choi, E. K.
    Han, K. D.
    Kim, D. H.
    Lee, E.
    Lee, S. R.
    Oh, S.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2020, 41 : 474 - 474
  • [19] Effect of dapagliflozin on atrial fibrillation/flutter in patients with Type 2 Diabetes mellitus: insights from the DECLARE-TIMI 58 trial
    Zelniker, T.
    Bonaca, M.
    Mosenzon, O.
    Kuder, J.
    Murphy, S.
    Remo, F.
    Deepak, B.
    Leiter, L.
    McGuire, D.
    Wilding, J.
    Budaj, A.
    Kiss, G.
    Padilla, F.
    Gause-Nilsson, I.
    Langkilde, A. M.
    Raz, I.
    Sabatine, M.
    Wiviott, S.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S158 - S158
  • [20] Effect of Dapagliflozin on Atrial Fibrillation/Flutter in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial
    Zelniker, Thomas A.
    Bonaca, Marc P.
    Mosenzon, Ofri
    Kuder, Julia F.
    Murphy, Sabina A.
    Furtado, Remo H.
    Bhatt, Deepak L.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Wilding, John P.
    Budaj, Andrzej
    Kiss, Robert Gabor
    Padilla, Francisco
    Gause-Nilsson, Ingrid A.
    Langkilde, Anna Maria
    Raz, Itamar
    Sabatine, Marc S.
    Wiviott, Stephen D.
    CIRCULATION, 2019, 140